We serve Fmoc-L-Orn(Boc)-OH CAS:109425-55-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid
CAS.NO: 109425-55-0
Molecular Formula: C25H30N2O6
Molecular Weight: 454.51600
Synonyms:
L-Ornithine, N-[(1,1-dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-
N-(tert-Butoxycarbonyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-ornithine
Ndelta-Boc-Nalpha-Fmoc-L-ornithine
Fmoc-L-Orn(Boc)-OH
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-N-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-ornithine
Nδ-Boc-Nα-Fmoc-L-ornithine
Nalpha-Fmoc-Ndelta-Boc-L-ornithine
Nδ-(tert-Butoxycarbonyl)-Nα-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-ornithine
Fmoc-Orn(Boc)-OH
Physical and Chemical Properties:
Density: 1.226 g / cm3
Boiling point: 679ºC at 760 mmHg
Melting point: 111-115ºC
Flash point: 364.5ºC
Refractive index: 1.57
Specification:
Appearance: White to off-white powder
Purity:≥98%
Loss on drying:≤0.5%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at 2-8ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.
Contact us for information like (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Fmoc-Orn(Boc)-OH physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ndelta-Boc-Nalpha-Fmoc-L-ornithine Use and application,Ndelta-Boc-Nalpha-Fmoc-L-ornithine technical grade,usp/ep/jp grade.
Related News: What are the symptoms? Coronavirus symptoms can look like the flu — fever, cough, trouble breathing. If you show these symptoms and recently went to China, or have been in contact with someone who visited, experts advise going to the doctor.2-n-Propyl-4-Methyl-6-(1’-Methylbenzimidazol-2’-yl)Benzimidazole manufacturer Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).4-[(2R)-2-(Chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene supplier Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition.chlorodimethylvinylsilane vendor Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition.AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer.
